Skopos Labs, Inc. Mirum Pharmaceuticals, Inc. Transaction History
Skopos Labs, Inc.
- $453 Million
- Q1 2025
A detailed history of Skopos Labs, Inc. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 235 shares of MIRM stock, worth $10,802. This represents 0.0% of its overall portfolio holdings.
Number of Shares
235Holding current value
$10,802% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MIRM
# of Institutions
225Shares Held
55.4MCall Options Held
27.4KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$312 Million19.27% of portfolio
-
Janus Henderson Group PLC London, X04.77MShares$219 Million0.12% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$149 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$129 Million5.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$117 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.69B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...